Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Parkinson's disease and fatigue.

Literature DB >> 17131229

Parkinson's disease and fatigue.

Fumihito Yoshii¹, Hirohide Takahashi, Ryuya Kumazawa, Satoko Kobori.

Abstract

Fatigue is one of the most common symptoms in patients with Parkinson's disease (PD), and its impact on the quality of life is substantial. However, its cause and treatment are not established. Fatigue in PD has two components, peripheral and central, which may be related to each other, but are more likely independent. Fatigue is partially associated with depression or sleep disorders, but patients with fatigue are not always depressed and do not necessarily have sleep problems. Anti-PD drugs may exacerbate or reduce fatigue. The impact of fatigue in PD is often underestimated by health-care providers.

Entities: Disease Species

Mesh：

Year: 2006 PMID： 17131229 DOI： 10.1007/s00415-006-7011-6

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

61 in total

1. Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity.

Authors: H S Markus; M Cox; A M Tomkins
Journal: Clin Sci (Lond) Date: 1992-08 Impact factor: 6.124

2. The Parkinson fatigue scale.

Authors: R G Brown; A Dittner; L Findley; S C Wessely
Journal: Parkinsonism Relat Disord Date: 2005-01 Impact factor: 4.891

3. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome.

Authors: K Y Fulcher; P D White
Journal: BMJ Date: 1997-06-07

4. What contributes to depression in Parkinson's disease?

Authors: A Schrag; M Jahanshahi; N P Quinn
Journal: Psychol Med Date: 2001-01 Impact factor: 7.723

5. Fatigue in patients with Parkinson's disease.

Authors: K Karlsen; J P Larsen; E Tandberg; K Jørgensen
Journal: Mov Disord Date: 1999-03 Impact factor: 10.338

6. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine.

Authors: P M Rossini; P Pasqualetti; C Pozzilli; M G Grasso; E Millefiorini; A Graceffa; G A Carlesimo; G Zibellini; C Caltagirone
Journal: Mult Scler Date: 2001-12 Impact factor: 6.312

7. NCCN Practice Guidelines for Cancer-Related Fatigue.

Authors: V Mock; A Atkinson; A Barsevick; D Cella; B Cimprich; C Cleeland; J Donnelly; M A Eisenberger; C Escalante; P Hinds; P B Jacobsen; P Kaldor; S J Knight; A Peterman; B F Piper; H Rugo; P Sabbatini; C Stahl
Journal: Oncology (Williston Park) Date: 2000-11 Impact factor: 2.990

8. Parkinsonism: onset, progression and mortality.

Authors: M M Hoehn; M D Yahr
Journal: Neurology Date: 1967-05 Impact factor: 9.910

9. Symptomatic fatigue in multiple sclerosis.

Authors: J E Freal; G H Kraft; J K Coryell
Journal: Arch Phys Med Rehabil Date: 1984-03 Impact factor: 3.966

Review 10. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors: David J Burn
Journal: Mov Disord Date: 2002-05 Impact factor: 10.338

5 in total

5. Fatigue After Aneurysmal Subarachnoid Hemorrhage: Clinical Characteristics and Associated Factors in Patients With Good Outcome.

Authors: Elin Western; Tonje Haug Nordenmark; Wilhelm Sorteberg; Tanja Karic; Angelika Sorteberg
Journal: Front Behav Neurosci Date: 2021-05-12 Impact factor: 3.558